Montana begins Medicaid work requirement enforcement Oct. 1 as patients grapple with unclear letters
Montana begins enforcing Medicaid work requirements Oct. 1, leaving patients confused over contradictory letters.
CLAY TRIBUNE / THE ARCHIVE
Category: Health
Woman Diagnosed With Rare Condition Behind Decades of Dizziness and Falling
A woman's five-year struggle with balance and walking was caused by a rare disorder, and the correct diagnosis finally brought relief.
Experts agree kratom and 7-OH need regulating, but they can’t settle on the rules
Kratom and 7-OH should be regulated, but experts disagree on how. Here's where the DEA stands and what states are doing.
HHS Report Claims Gender-Affirming Care ‘May’ Radicalize — Critics Say the Evidence Isn’t There
A report from a right-leaning institute ties gender-affirming care to left-wing authoritarian psychology. Experts call it pseudoscience.
New obesity drug helped people lose up to a quarter of their body weight in tests
New obesity drug trial shows 25% weight loss at 80 weeks, rising to 30% at 104 weeks, with major health benefits.
Infection link behind one in eight cancers worldwide, new research shows
A study links one in eight cancers worldwide to infections like HPV, HBV, HCV, and Helicobacter pylori, urging broader prevention efforts.
Fruit flies live longer when maggots raised on less protein
A protein records a fly's larval diet, carrying that memory into adulthood and shaping how long that fly lives.
AstraZeneca Invests $2 Billion in Summit Therapeutics as Four Deals Land Overnight
AstraZeneca invests $2 billion in Summit Therapeutics, Novo buys a Chinese obesity pill, and two biotech deals go the other way.
The Toy Insider rounds up 20 gifts worth buying now, from robot dogs to coding kits
A rundown of the Toy Insider's 2026 picks, from a hiccuping Elmo to a fizzy shark egg, plus a playable mini record player.
Novo Agrees to Pay Up to $2.6 Billion for Hengrui Obesity Pill License
Novo Nordisk licenses a Chinese obesity pill, Roche quits a drug, and other pharma tidbits. A look at who's winning and losing in weight-loss meds.
UniQure Reports Gene Therapy Slows Huntington’s Disease Progression Over Four Years
UniQure's gene therapy slows Huntington's progression for four years, but data lacks statistical significance ahead of FDA review.
The Case Against America’s Children: Why Protecting Their Health Should Be a Priority
Pediatricians, generals, and researchers warn that America's declining child health is a national security crisis.